Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles

Assessing ovarian response: antral follicle count versus anti-Müllerian hormone

(2015) Richard Fleming et al.   REPRODUCTIVE BIOMEDICINE ONLINE

GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: A retrospective study of OHSS risk and pregnancy rates

(2014) Paul Atkinson et al.   AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis

(2014) Jin-song Xiao et al.   PLoS One

Ovarian Antral Follicle Subclasses and Anti-Müllerian Hormone During Normal Reproductive Aging

(2013) J. G. Bentzen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial

(2012) Yannis Prapas et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study

(2011) Georg Griesinger et al.   FERTILITY AND STERILITY

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

(2011) P. Humaidan et al.   HUMAN REPRODUCTION UPDATE

Preventing ovarian hyperstimulation syndrome: guidance for the clinician

(2010) Peter Humaidan et al.   FERTILITY AND STERILITY

A modern classification of OHSS

(2010) Abraham Golan et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)

(2009) Trifon G. Lainas et al.   HUMAN REPRODUCTION

Ovarian hyperstimulation syndrome

(2008)   FERTILITY AND STERILITY

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

(2007) Lawrence Engmann et al.   FERTILITY AND STERILITY